VN1R107P

Across TCGA pan-cancer cohorts, VN1R107P RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of VN1R107P’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where VN1R107P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R107P is over-expressed in tumor, although a few such as COAD and STAD show the opposite, repressed pattern.

CHOL, LIHC, and PAAD are the cancer types where VN1R107P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R107P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	II,III,IV	+1.345	.003	5	view →
LIHC	All	All	+0.294	<.001	5	view →
PAAD	All	All	+0.955	.009	4	view →
BRCA	All	II,III,IV	+0.406	.001	4	view →
LUSC	Male	All	+0.344	.002	4	view →
COAD	All	II,III,IV	−0.262	.002	4	view →
KICH	All	II,III,IV	+0.488	.041	3	view →
STAD	Female	All	−0.848	.032	2	view →
THCA	Female	II,III,IV	−0.457	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

VN1R107P–CHOL

Open the CHOL breakdown →